Direct Oral Anticoagulants

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

• Revision history
  • April 2022; March 2020; May 2018; Feb. 2018.
• Initially developed
  • March 2017